As Congress returns from its August recess, House Republicans face a challenging task in passing a stopgap funding legislation. A key point of contention involves a provision that delays a prohibition on most hemp-derived THC products until December 11. Notable among the opposition is Andy Harris, the House Freedom Caucus Chairman, who has vocalized his concerns about the provision.

In a conversation with a Baltimore Fox affiliate, Harris expressed skepticism about the products marketed as ‘gas station weed.’ He stressed that these items are not hemp, but rather unregulated marijuana. He described the federal government’s regulation failure and called for an end to the sale of such products. As the chairman of the House Agriculture Appropriations Subcommittee, alongside Senator Mitch McConnell, Harris played a pivotal role in the legislation that initially established the ban.

The White House’s push for delaying the ban aims to provide hemp industry advocates more time to persuade lawmakers to consider regulating instead of outright banning hemp-derived products. The Senate faced its own set of hurdles with this issue earlier in the month. An attempted amendment by Senator Ted Budd to remove the delay provision was ultimately tabled, with a vote of 61-32. The opposition bloc included a mix of 21 Republicans and 11 Democrats. Despite this setback, GOP senators are signalling their plans to push for the ban in upcoming sessions.

The current funding bill remains effective through December 11, with the White House reportedly indicating no further delay requests. As legislative proceedings continue, the resolution of the hemp ban remains crucial.

Turning to healthcare developments, the Food and Drug Administration has granted approval for updated COVID-19 vaccines targeting high-risk groups. These new formulations, developed by Pfizer-BioNTech and Moderna, will soon be distributed to pharmacies and physicians’ offices. Additionally, a non-mRNA vaccine, initially licensed to Novavax and now approved from Sanofi, is part of this update.

Top Trump administration health officials have raised queries regarding two deaths in Pennsylvania attributed to measles by state officials. Dr. Mehmet Oz, representing the Centers for Medicare and Medicaid Services, has publicly expressed uncertainties about the exact causes. Meanwhile, South Carolina Senate Democratic nominee Annie Andrews dismissed Medicare for All as outdated during her campaign, suggesting a pragmatic approach emphasizing modern policies for current healthcare challenges.